However, this differs from previous results in cancer cells and heart fibroblasts where WISP2 is a powerful inhibitor of TGFβ activation, inhibiting epithelial-mesenchymal cell transition11 as well as the development of myofibroblast-induced fibrosis when expressed in the heart12. Here, TGFB1 is linked to cancer.